Latest PTO Ruling On Cabilly May Offer Ray Of Hope To Genentech Licensees
Executive Summary
The U.S. Patent and Trademark Office's rejection of Genentech's Cabilly patent was little surprise after the office's non-final rejection in 2005, but it may make Genentech's licensees more upbeat now that an end to royalty payments is a small step closer